Yüklüyor......
The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data
OBJECTIVE: This study aims to evaluate the efficacy and safety of the addition of 10 or 25 mg of empagliflozin to patients with type 2 diabetes mellitus using a maximum tolerable dose of metformin and gliclazide. METHODS: A total of 60 patients who had been receiving a maximum tolerable dose of metf...
Kaydedildi:
| Yayımlandı: | North Clin Istanb |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Kare Publishing
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7117635/ https://ncbi.nlm.nih.gov/pubmed/32259039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/nci.2019.22697 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|